| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0088 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |